North Star Investment Management Corp. Biocryst Pharmaceuticals Inc Transaction History

North Star Investment Management Corp.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$4.89 - $7.65 $977 - $1,530	200 New	200 $1,000
Q1 2023 Apr 27, 2023	SELL	$7.94 - $11.84 $2.76 Million - $4.11 Million	-347,300 Reduced 94.55%	20,000 $166,000
Q4 2022 Jan 11, 2023	SELL	$10.5 - $14.2 $783,300 - $1.06 Million	-74,600 Reduced 16.88%	367,300 $0
Q2 2022 Jul 19, 2022	SELL	$7.89 - $17.88 $11,835 - $26,820	-1,500 Reduced 0.34%	441,900 $4.68 Million
Q1 2022 May 03, 2022	SELL	$11.56 - $19.76 $73,984 - $126,464	-6,400 Reduced 1.42%	443,400 $7.21 Million
Q4 2021 Feb 07, 2022	BUY	$11.18 - $15.46 $77,142 - $106,674	6,900 Added 1.56%	449,800 $6.23 Million
Q3 2021 Oct 20, 2021	BUY	$14.21 - $17.65 $88,244 - $109,606	6,210 Added 1.42%	442,900 $6.36 Million
Q2 2021 Jul 13, 2021	BUY	$9.5 - $17.24 $8,550 - $15,515	900 Added 0.21%	436,690 $6.9 Million
Q1 2021 Apr 19, 2021	BUY	$7.37 - $13.61 $999,372 - $1.85 Million	135,600 Added 45.17%	435,790 $4.43 Million
Q4 2020 Jan 12, 2021	BUY	$3.37 - $8.61 $421,890 - $1.08 Million	125,190 Added 71.54%	300,190 $2.24 Million
Q3 2020 Oct 13, 2020	BUY	$3.43 - $5.53 $463,050 - $746,550	135,000 Added 337.5%	175,000 $601,000
Q2 2020 Jul 16, 2020	BUY	$1.9 - $5.61 $76,000 - $224,400	40,000 New	40,000 $191,000

279

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

Stay updated on North Star Investment Management Corp. with notifications on news.